Clinical Trial Update: A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing CagriSema to semaglutide, cagrilintide, and placebo in adults with Type 2 diabetes treated with metformin (with or without an SGLT2 in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)
• Cagrilintide (cagrilintide)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED